Please login to the form below

Not currently logged in
Email:
Password:

European Excellence Award for MS&L London

MS&L London has received a European Excellence Award for 'Asbestos – The Hidden Killer' on behalf of the HSE

MS&L London has received a European Excellence Award in the Health category for the campaign 'Asbestos – The Hidden Killer' on behalf of the Health & Safety Executive (HSE).

The campaign was targeted at workmen and aimed to raise awareness of the dangers of exposure to asbestos. The campaign used a football analogy to reach its target audience and was spearheaded by ex-England footballer, Ian Wright.

Steve Coldrick, HSE's asbestos programme director said: "Asbestos remains Britain's biggest workplace killer, but with the perception that it is largely a risk of the past we needed a hard-hitting PR campaign that would capture the imagination of tradesmen, particularly young ones. Using Ian Wright, a former plasterer, ticked all the boxes for us and delivered great results."

The European Excellence Awards honour outstanding achievement in the PR profession. Having been shortlisted three times, this is the second time HSE's campaign has won an award.

17th December 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics